Bottom line
How much do ETHSX and SCHLX overlap?
70% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 72.0% of ETHSX's assets and 62.1% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings ETHSX and SCHLX have in common
| Holding | % of ETHSX | % of SCHLX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 12.47% | 13.85% | 12.47% |
| AbbVie Inc | 6.46% | 4.90% | 4.90% |
| Johnson & Johnson | 6.45% | 6.19% | 6.19% |
| AstraZeneca PLC | 6.24% | 3.80% | 3.80% |
| UnitedHealth Group Inc | 5.49% | 5.73% | 5.49% |
| Roche Holding AG | 5.44% | 1.24% | 1.24% |
| Merck & Co Inc | 5.08% | 4.85% | 4.85% |
| Bristol-Myers Squibb Co | 4.25% | 1.50% | 1.50% |
| Vertex Pharmaceuticals Inc | 3.38% | 2.45% | 2.45% |
| Gilead Sciences Inc | 3.34% | 2.78% | 2.78% |
| Thermo Fisher Scientific Inc | 2.79% | 3.46% | 2.79% |
| Intuitive Surgical Inc | 2.72% | 2.69% | 2.69% |
| Stryker Corp | 2.21% | 2.61% | 2.21% |
| Boston Scientific Corp | 2.18% | 2.10% | 2.10% |
| Medtronic PLC | 1.80% | 1.54% | 1.54% |
| Abbott Laboratories | 1.65% | 2.39% | 1.65% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in ETHSX
- Sanofi SA — 2.95%
- Lonza Group AG — 1.77%
- Novo Nordisk A/S — 1.71%
- Novartis AG — 1.65%
- Argenx SE — 1.61%
- Royalty Pharma PLC — 1.58%
- Neurocrine Biosciences Inc — 1.41%
- Mettler-Toledo International Inc — 1.36%
- Straumann Holding AG — 1.34%
Only in SCHLX
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Danaher Corp — 2.13%
- McKesson Corp — 2.05%
- Novo Nordisk A/S — 1.73%
- Regeneron Pharmaceuticals Inc — 1.43%
- Cardinal Health Inc — 1.34%
- Cencora Inc — 1.26%
- Pfizer Inc — 1.17%
Asset mix
| Asset type | ETHSX | SCHLX |
|---|---|---|
| Stocks | 99.4% | 99.6% |
| Cash & short-term funds | 0.3% | 0.5% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Country mix
| Country | ETHSX | SCHLX |
|---|---|---|
| US | 69.4% | 85.7% |
| CH | 10.2% | 5.2% |
| GB | 7.8% | 3.8% |
| FR | 3.2% | 1.0% |
| DK | 2.9% | 1.7% |
| NL | 2.0% | 1.0% |
| IE | 1.8% | 1.5% |
| AU | 0.9% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do ETHSX and SCHLX overlap?
What stocks do ETHSX and SCHLX have in common?
Should I own both ETHSX and SCHLX?
Which holds more stocks, ETHSX or SCHLX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.